Covid-19 roundup: EU looks to pre-or­der vac­cines from Mod­er­na, Sanofi, J&J, BioN­Tech, Cure­Vac — re­port

The EU has re­port­ed­ly locked down a fi­nal group of Covid-19 vac­cine de­vel­op­ers it wants to place ad­vance pur­chas­es from.

Mod­er­na, Sanofi, J&J, BioN­Tech and Cure­Vac are all at the deal ta­ble, sources tell Reuters. The Eu­ro­pean Com­mis­sion, which has a $2.7 bil­lion rainy day fund ear­marked for this pur­pose, con­firmed to the news wire that it’s in talks with sev­er­al com­pa­nies but de­clined to name them.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER